Axsome therapeutics inc.

Major-Pharmaceuticals

AXSM


25 Broadway
New York , NY 10004

Executive/
Director

Price

  • Last Close
  • $ 100.11
    $ +1.72 1.75 %
    Dec 6, 2024
  • 52-Week High/Low
  • $97.64 - $57.42
  • YTD
  • 25.8%

  • Trading Volume
  • 12,487
  • Market Cap Full
  • $ 4.7B
  • Shares Outstanding
  • 47.3M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -7.2% -42.2% -56.3% 404.6% -5% -30.5% 9.6% -20% 0.3%
Q2 - -12.3% 41% 42.2% 90.4% 4% 19.2% -7.5% 16.5% -3.2%
Q3 - 4.5% 0.9% 9.5% -16.8% 8% -51.1% 16.5% -2.7% -
Q4 6.1% -14.3% -0.9% -22.1% 401.1% 13.3% 14.6% 72.9% 19.1% -
J F M A M J J A S O N D
2024 13.1% -9.6% -1.9% -6.6% - - - - - - - -
2023 -2.8% -9.1% -9.6% 16% 3.2% -2.6% 9.2% 3% -13.5% -10.9% 8.3% 18%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-27%-17%-50%3685%-24%-54%104%3%26%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.31 0.41 -0.19 -0.32 -0.88 -0.78 -1.03 -0.26
Q2 - 0.36 0.30 -0.32 -0.41 -0.49 -0.86 -1.06 -1.54
Q3 - 0.38 0.27 -0.31 -0.56 -0.61 -0.93 -1.07 -1.32
Q4 0.12 0.38 0.28 -0.33 -0.72 -0.79 -0.9 -1.44 -
A 0.1 1.4 1.3 -1.2 -2 -2.8 -3.5 -4.6 -3.12

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 33.3 37.1 37.4 38.5 43.5
Jun 25.7 33.3 37.1 37.6 38.9 43.6
Sep 26.3 34.4 37.3 37.7 40.3 47.2
Dec 29.8 34.5 37.3 37.7 43.4 47.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.3 - - - -
Fixed Asset Turnover 3.1 - - - -
Total Asset Turnover 0.2 - - - -
Leverage
Debt Ratio 0.4 0.6 0.3 0.1 0.3
Debt – Equity Ratio 0.9 3.1 0.4 0.1 4
Interest Coverage -25.7 -25 -24.8 -67 16.5
Equity multiplier 0.2 - - - -